Pre-treatment with an intravenous lipid emulsion containing fish oil (eicosapentaenoic and docosahexaenoic acid) decreases inflammatory markers after open-heart surgery in infants: A randomized, controlled trial

Clinical Nutrition

Volumn 31, Issue 3, 2012, Pages 322-329

  Larsen, Bodil M K ^a,b   Goonewardene, Laksiri A ^b,c   Joffe, Ari R ^b   Van Aerde, John E ^b   Field, Catherine J ^b   Olstad, Dana Lee ^b   Clandinin, Michael T ^b  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ALBERTA AGRICULTURE AND RURAL DEVELOPMENT   (Canada)

Author keywords

Critical care; Docosahexaenoic acids; Eicosapentaenoic acid; Fat emulsions; Inflammation; Intravenous; Randomized controlled trial

Indexed keywords

DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPID EMULSION; MEDIUM CHAIN TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIRTH WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; HIGH RISK INFANT; HUMAN; INFANT; INFLAMMATION; LENGTH OF STAY; MALE; NECROTIZING ENTEROCOLITIS; OPEN HEART SURGERY; OPERATION DURATION; PARENTERAL NUTRITION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TREATMENT OUTCOME;

ALBERTA; CARDIOPULMONARY BYPASS; COHORT STUDIES; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; INFLAMMATION MEDIATORS; LENGTH OF STAY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SEPSIS; SOYBEAN OIL;

EID: 84861339382     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.11.006     Document Type: Article

References (42)

1. Oberholzer A., Oberholzer C., Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96.
2. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
3. Valentine C.J., Puthoff T.D. Enhancing parenteral nutrition therapy for the neonate. Nutr Clin Pract 2007, 22:183-193.
4. Gariballa S., Forster S. Effects of acute-phase response on nutritional status and clinical outcome of hospitalized patients. Nutrition 2006, 22:750-757.
5. Seghaye M.C., Duchateau J., Grabitz R.G., Faymonville M.L., Messmer B.J., Buro-Rathsmann K., et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993, 106:978-987.
6. Seghaye M.C., Grabitz R.G., Duchateau J., Busse S., Dabritz S., Koch D., et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996, 112:687-697.
7. Hulst J.M., van Goudoever J.B., Zimmermann L.J., Hop W.C., Albers M.J., Tibboel D., et al. The effect of cumulative energy and protein deficiency on anthropometric parameters in a pediatric ICU population. Clin Nutr 2004, 23:1381-1389.
8. Hulst J.M., Joosten K.F., Tibboel D., van Goudoever J.B. Causes and consequences of inadequate substrate supply to pediatric ICU patients. Curr Opin Clin Nutr Metab Care 2006, 9:297-303.
9. Avitzur Y., Singer P., Dagan O., Kozer E., Abramovitch D., Dinari G., et al. Resting energy expenditure in children with cyanotic and noncyanotic congenital heart disease before and after open heart surgery. J Parenter Enteral Nutr 2003, 27:47-51.
10. Nydegger A., Bines J.E. Energy metabolism in infants with congenital heart disease. Nutrition 2006, 22:697-704.
11. Tilley S.L., Coffman T.M., Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Investig 2001, 108:15-23.
12. Koch T., Heller A. Effects of parenteral nutrition with n-3 fatty acids on the result of therapy - a multi-centre analysis with 661 patients. Aktuelle Ernahrungsmedizin 2005, 30:15-22.
13. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J., Spur B.W., et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985, 312:1217-1224.
14. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonnemann G., van der Meer J.W., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.
15. von Schacky C., Kiefl R., Jendraschak E., Kaminski W.E. N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo. J Lab Clin Med 1993, 121:302-309.
16. 2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr 2003, 78:376-382.
17. Goldstein B., Giroir B., Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Medicine a J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Societies 2005, 6:2-8.
18. Pollack M.M., Patel K.M., Ruttimann U.E. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996, 24:743-752.
19. Schauder P., Rohn U., Schafer G., Korff G., Schenk H.D. Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br J Nutr 2002, 87(Suppl. 1):S103-S110.
20. Wang Z., Goonewardene L.A. The use of mixed models in the analysis of animal experiments with repeated measures data. Can J Anim Sci 2004, 84:1-11.
21. Tappy L., Berger M.M., Schwarz J.M., Schneiter P., Kim S., Revelly J.P., et al. Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 2006, 25:588-595.
22. Barbosa V.M., Miles E.A., Calhau C., Lafuente E., Calder P.C. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010, 14:R5.
23. Tsekos E., Reuter C., Stehle P., Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 2004, 23:325-330.
24. Furukawa K., Yamamori H., Takagi K., Hayashi N., Suzuki R., Nakajima N., et al. Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 2002, 18:235-240.
25. Mayer K., Fegbeutel C., Hattar K., Sibelius U., Kramer H.J., Heuer K.U., et al. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003, 29:1472-1481.
26. Mayer K., Gokorsch S., Fegbeutel C., Hattar K., Rosseau S., Walmrath D., et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003, 167:1321-1328.
27. Wichmann M.W., Thul P., Czarnetzki H.D., Morlion B.J., Kemen M., Jauch K.W. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 2007, 35:700-706.
28. Weiss G., Meyer F., Matthies B., Pross M., Koenig W., Lippert H. Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 2002, 87(Suppl. 1):S89-S94.
29. Heller A.R., Rossel T., Gottschlich B., Tiebel O., Menschikowski M., Litz R.J., et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Intl J Cancer 2004, 111:611-616.
30. Wanten G.J., Calder P.C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007, 85:1171-1184.
31. Calder P.C. Immunonutrition in surgical and critically ill patients. Br J Nutr 2007, 98(Suppl. 1):S133-S139.
32. Versleijen M., Roelofs H., Preijers F., Roos D., Wanten G. Parenteral lipids modulate leukocyte phenotypes in whole blood, depending on their fatty acid composition. Clin Nutr 2005, 24:822-829.
33. Versleijen M.W., Oyen W.J., Roelofs H.M., van Emst-de Vries S.E., Willems P.H., Jansen J.B., et al. Immune function and leukocyte sequestration under the influence of parenteral lipid emulsions in healthy humans: a placebo-controlled crossover study. Am J Clin Nutr 2008, 87:539-547.
34. Song J.H., Fujimoto K., Miyazawa T. Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils. J Nutr 2000, 130:3028-3033.
35. Goulet O., Antebi H., Wolf C., Talbotec C., Alcindor L.G., Corriol O., et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. J Parenter Enteral Nutr 2010, 34:485-495.
36. Smith E.M., Cadet P., Stefano G.B., Opp M.R., Hughes T.K. IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 1999, 100:140-148.
37. van Deventer S.J. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 2000, 26(Suppl. 1):S98-S102.
38. Trotter A., Muck K., Grill H.J., Schirmer U., Hannekum A., Lang D. Gender-related plasma levels of progesterone, interleukin-8 and interleukin-10 during and after cardiopulmonary bypass in infants and children. Crit Care 2001, 5:343-348.
39. Hovels-Gurich H.H., Schumacher K., Vazquez-Jimenez J.F., Qing M., Huffmeier U., Buding B., et al. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 2002, 73:601-608.
40. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Investig 1996, 97:713-719.
41. Tassani P., Barankay A., Haas F., Paek S.U., Heilmaier M., Hess J., et al. Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns. J Thorac Cardiovasc Surg 2002, 123:648-654.
42. Alaedeen D.I., Queen A.L., Leung E., Liu D.D.J. C. C-Reactive protein-determined injury severity: length of stay predictor in surgical infants. J Pediatr Surg 2004, 39:1832-1834.